HOME >> MEDICINE >> NEWS
Radiation, chemotherapy before surgery controls rectal cancer

For patients with rectal cancer, receiving radiation therapy and chemotherapy before surgery to shrink the tumor so it can be more easily removed helps keep the cancer from coming back, according to a study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.

Beginning in 1992, doctors in France enrolled 733 patients suffering from rectal cancer into the study. The patients were split into two groups the first received radiation alone for five weeks before undergoing surgery to remove the cancer. The second group received chemotherapy in addition to five weeks of radiation therapy prior to surgery.

"The standard treatment for rectal cancer has been radiation therapy alone before surgery, but this is the first randomized study to prove that adding chemotherapy to the treatment helps patients beat their cancer," said Pascale Romestaing, M.D., co-author of the study and a radiation oncologist at CHU Lyon Sud in Lyon, France.

The doctors discovered that while combining radiation therapy and chemotherapy does not significantly increase survival rates, it does improve local tumor control and helps to keep the cancer from returning. The last phase of the trial, from 1999 to 2003, showed that only eight percent of the patients saw their cancer return five years after receiving treatment.

"This treatment should be recommended as the standard for the majority of rectal cancer patients," said Jean-Pierre Gerard, M.D., lead author of the study and a radiation oncologist at the Centre Antoine-Lacassagne in Nice, France.


'"/>

Contact: Beth Bukata
bethb@astro.org
703-431-2332
American Society for Therapeutic Radiology and Oncology
17-Oct-2005


Page: 1

Related medicine news :

1. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
2. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
3. Brain-boosting pill alleviates post-chemotherapy fogginess
4. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
5. Most pediatric chemotherapy mistakes reach patients
6. Growth factors given with chemotherapy associated with increased risk of blood diseases
7. Clear guidelines on oral chemotherapy needed
8. Survey reveals need for standardized oral chemotherapy prescribing practices, safeguards
9. Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
10. Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival
11. Order of chemotherapy, radiation has no effect on breast cancer survival

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Radiation chemotherapy before surgery controls rectal cancer

(Date:11/27/2014)... 2014 HealthPostures, a leading ... , has announced that it has entered into ... The partnership will put HealthPostures' products into central ... In addition to having its products sold through ... HealthPostures' products with the business decision makers in ...
(Date:11/27/2014)... Philadelphia, PA (PRWEB) November 27, 2014 ... alongside volunteer Aria Health employees, prepared and donated ... to the Lutheran Settlement House , a non-profit, ... and families living in Philadelphia. The dinners were ... Settlement House Senior Center, and distributed to vulnerable ...
(Date:11/27/2014)... November 27, 2014 Allowing children to help ... during school, helps give children responsibility, ownership, boosts self-esteem, and ... , Now, the real question is, how do you ... secret? According to a study published by Child Development Journal, ... a dramatic effect on a child’s willingness to lend a ...
(Date:11/27/2014)... 27, 2014 At The Little Gym, ... it came as no surprise when a recent study ... academic success. The Journal of Pediatrics found ... motor tasks during the school years may be important ... development.” The study monitored two groups of children; those ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. "Every ... as we enjoy the ugly sweater contest." Last year's ... " It was a sight to see. She glued ... the Christmas balls were faces of the staff with Dr. ... this year, it's simple to get in on the fun. ...
Breaking Medicine News(10 mins):Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3
(Date:11/26/2014)... 26, 2014  Cohen, Placitella & Roth, PC ... who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") ... from January 31, 2011 through November 2, 2014 ... certain of its officers and directors publically disseminated ... Sections 10(b) and 20(a) of the Securities Exchange ...
(Date:11/26/2014)... , Nov. 26, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... U.S. Food and Drug Administration (FDA) has issued ... Application (NDA) for AVP-825. AVP-825 is an investigational ... delivered intranasally utilizing a novel Breath Powered delivery ... letter, and consistent with the preliminary feedback announced ...
(Date:11/26/2014)... , Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... , President and Chief Executive Officer, will present at the Bank ... , , , Date: , , , Wednesday, December ... 2:50 p.m. EST , , , , Location: , , ... About BioScrip, Inc. BioScrip, Inc. ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
Cached News: